Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society.
Whelan
Mary Anne
MA
Delgado
Mauricio R
MR
D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000150:complications; D002648:Child; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology; D009498:Neurotoxins / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic / Q000592:standards*
D009498:Neurotoxins; D019274:Botulinum Toxins, Type A